Geschlechtsspezifische Unterschiede in Diagnostik und Therapie entzündlich-rheumatischer ErkrankungenGender-specific differences in the diagnosis and treatment of inflammatory rheumatic diseases

[1] Smolen JS(2020)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Ann Rheum Dis 79 685-699

[2] Landewe RBM(2022)Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis Nat Rev Rheumatol 58 1634-1638

[3] Bijlsma JWJ(2019)Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data Rheumatology 24 22-183

[4] Burmester GR(2022)Sex-specific differences and how to handle them in early psoriatic arthritis Arthritis Res Ther 44 174-413

[5] Dougados M(2017)Understanding how the diagnostic delay of spondyloarthritis differs between women and men: a systematic review and metaanalysis J Rheumatol 13 e0205751-75

[6] Kerschbaumer A(2018)Challenges to conquer from the gender perspective in medicine: The case of spondyloarthritis PLoS ONE 73 407-706

[7] McInnes IB(2014)Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA) Ann Rheum Dis 36 Suppl 113 68-754

[8] Sepriano A(2022)Sex-specific differences in patients with Psoriatic arthritis: a systematic review J Rheumatol 26 698-e678

[9] van Vollenhoven RF(2018)Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database Clin Exp Rheumatol 6 86-571

[10] de Wit M(2017)Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort Lupus 4 e003888-677

[1] Smolen JS(2020)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Ann Rheum Dis 79 685-699

[2] Landewe RBM(2022)Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis Nat Rev Rheumatol 58 1634-1638

[3] Bijlsma JWJ(2019)Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data Rheumatology 24 22-183

[4] Burmester GR(2022)Sex-specific differences and how to handle them in early psoriatic arthritis Arthritis Res Ther 44 174-413

[5] Dougados M(2017)Understanding how the diagnostic delay of spondyloarthritis differs between women and men: a systematic review and metaanalysis J Rheumatol 13 e0205751-75

[6] Kerschbaumer A(2018)Challenges to conquer from the gender perspective in medicine: The case of spondyloarthritis PLoS ONE 73 407-706

[7] McInnes IB(2014)Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA) Ann Rheum Dis 36 Suppl 113 68-754

[8] Sepriano A(2022)Sex-specific differences in patients with Psoriatic arthritis: a systematic review J Rheumatol 26 698-e678

[9] van Vollenhoven RF(2018)Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database Clin Exp Rheumatol 6 86-571

[10] de Wit M(2017)Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort Lupus 4 e003888-677